2041-15-8

Usage

Uses

Used in Chemical or Biochemical Research:
1,3,5-Cyclohexanetriol is used as a research compound for its unique structural and functional properties, contributing to the understanding of chemical reactions and interactions involving polyols and cyclohexane derivatives. Its presence in research settings allows for the exploration of potential applications and effects in various scientific fields.

InChI:InChI=1/C6H12O3/c7-4-1-5(8)3-6(9)2-4/h4-9H,1-3H2

Upstream product

• 108-73-6 3,5-dihydroxyphenol 
• 7732-18-5 water 
• 64-17-5 ethanol 
• 91-17-8 decalin 

Downstream Products

• 58006-28-3 trans-1,3,5-triacetoxy-cyclohexane 
• 327622-76-4 cis,cis-3,5-di(methylcarbonyloxy)cyclohexyl acetate 
• 4096-20-2 N-phenyl piperidine 
• 956634-47-2 N-phenyl-4-tert-butyldimethylsiloxy-L-proline 
• 139356-35-7 (3R,5S)-3,5-bis[(tert-butyldimethylsilyl)oxy]cyclohexanone 

Relevant academic research and scientific papers

Efficient and Practical Arene Hydrogenation by Heterogeneous Catalysts under Mild Conditions

An efficient and practical arene hydrogenation procedure based on the use of heterogeneous platinum group catalysts has been developed. Rh/C is the most effective catalyst for the hydrogenation of the aromatic ring, which can be conducted in iPrOH under neutral conditions and at ordinary to medium H 2 pressures (10 atm). A variety of arenes such as alkylbenzenes, benzoic acids, pyridines, furans, are hydrogenated to the corresponding cyclohexyl and heterocyclic compounds in good to excellet yields. The use of Ru/C, less expensive than Rh/C, affords an effective and practical method for the hydrogenation of arenes including phenols. Both catalysts can be reused several times after simple filtration without any significant loss of catalytic activity.

Optically active phenoxypropionic esters

Optically active compounds of the formula I STR1 where R is C1 -C12 -alkyl or -perfluoroalkyl in which one or two non-adjacent CH2 or CF2 groups can also be replaced by --O-- and/or --CO-- and/or --CO--O-- and/or --CH=CH-- and/or --CH-halogen-- and/or --CHCN-- and/or --0--CO--CH-halogen-- and/or --O--CO--CHCN--, or is C1 -C12 -alkyl which can have a terminal chemically reactive group and in which a CH2 group can be replaced by --O--, A1 and A2 are each, independently of one another, 1,4-phenylene which is unsubstituted or substituted by one or two F and/or Cl and/or Br atoms and/or CH3 groups and/or CN groups and in which one or two CH groups can also be replaced by N, 1,4-cyclohexylene in which one or two non-adjacent CH2 groups can also be replaced by --O-- and/or --S--, 1,4-piperidinediyl, 1,4-bicyclo[2.2.2]octylene, 2,6-naphthalenediyl, decahydro-2,6-naphthalenediyl or 1,2,3,4-tetrahydro-2,6-naphthalenediyl, A3 is unsubstituted or substituted phenyl, Z is --CO--O--, --O--CO--, --CH2 CH2 --, --OCH2 --, --CH2 O--, --C C-- or a single bond and m is 0, 1, 2 or 3.

6-Substituted-4-hydroxy-tetrahydropyran-2-ones

6-Substituted-4-hydroxy-tetrahydropyran-2-ones, useful as anti-atherosclerotic agents, are obtainable by the process of the invention. The 6-substituents have a phenyl, naphthyl, tetrahydronaphthyl or indolyl nucleus bound through an ethenyl unit. The inv